Calypte und die Zeit nach AIDS2004 in Bangkok
Seite 22 von 203 Neuester Beitrag: 19.01.06 14:27 | ||||
| Eröffnet am: | 05.07.04 15:03 | von: Kade_I | Anzahl Beiträge: | 6.056 |
| Neuester Beitrag: | 19.01.06 14:27 | von: Der_wahre_. | Leser gesamt: | 187.751 |
| Forum: | Hot-Stocks | Leser heute: | 65 | |
| Bewertet mit: |  | |||
| Seite: < 1 | ... | 19 | 20 | 21 | | 23 | 24 | 25 | ... 203 > | ||||
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
Optionen
| Boardmail an "Börsenfan" |
Wertpapier: Calypte Biomedical |
mit der wette, die das ganze wieder auf eine recht sportliche ebene bringt, wollte ich eigentlich in normales fahrwasser zurückkehren, aber die meisten kleingeister hier halten nichts davon. spricht eben bände. vor allem: nach vorne raus laut tönen und wenn man die jungs dann darauf festzurren will, winden sie sich, wie die aale und werden ausfallen (lach...)
aber vieleicht ist es besser so, dann herrscht bald wieder ruhe...
aber: sehr überzeugt kannst du von deinem investment nicht sein, dass es besser ist, als meine...
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
Just talked to Tim Clemensen. I wanted to find out about the price of the test kits. He said the pricing has not been determined yet for each country but the range is anywhere from $1.00 to $5.00, depending on the location. He said in Africa the kit can't be any higher than $2.00. In America the kit might be priced around $5.00 for the OTC deluxe package.
Profits for each kit could range from 50% to 80% (depends on location of sales)
Possible CDC sales end of 3rd qtr.
Possible intrenational sales of rapid end of 4th qtr.
He has high regard for Dr. George.
Der Preis spricht für Caly!!
aus London
Jul 19, 11:34 PM EDT
Blair Renews Pledge to Tackle AIDS
LONDON (AP) -- Prime Minister Tony Blair has pledged to combat AIDS in developing countries, including $280.5 million for children left orphaned by the disease.
"Ignoring the issue of AIDS is simply not an option," said Blair, who was expected to meet Tuesday with some 20 AIDS victims from Africa, Asia and Eastern Europe.
The British government has promised to spend $2.8 billion over the next three years tackling the pandemic.
Government officials said Blair and International Development Secretary Hilary Benn would detail Tuesday how that money will be spent. It will include doubling to more than $280.5 million Britain's contribution over three years to the U.N.-sponsored global fund to fight AIDS, tuberculosis and malaria.
"This is a tragedy that spans personal and global scales," Blair said. "It is appalling that life expectancy in some of the worst-affected areas is falling back to pre-1950 levels. This is not just about millions of personal and family tragedies, appalling though these are.
"Already fragile economies are seeing their working-age population destroyed. Quite simply you cannot hope to tackle poverty on a global scale without addressing AIDS."
© 2004 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed
Sales results on this field.
The Future here is on The Rapid Tests.
The rapid Manufacturing Internationally will put us ahead of the competition NO QUESTION.
In addition to AIDS we will also be saleing other test products. As for the price of the stock, imo we will see 4-8 dlls once we crank up the manufacturing and sales.
Orasure is currently over 7 and their products dont begin to compare with ours once we are under full production capacity.
Please remember that Dr George was working for O prior tu joining C and has significant expertise on this field. His experience working for CDC -the center for disease control- the preeminent Center in the World should give ample credibility to the work currently being done by CYPT.
We should allready be at a higher pps were it not for some credibility issues.
CRANK IT UP CYPT.!!! enough is enough.
After-hours PR: Conference call tomorrow. . .
(PR NEWSWIRE) Calypte Biomedical To Host Conference Call
Calypte Biomedical To Host Conference Call
CEO to Discuss The International AIDS Conference and
Recent Clinical Data Disclosed at Event
Conference Call Scheduled for Tomorrow, Thursday, July 22, 2004
at 11:00AM EDT. Dial-In Number is 1-800-915-4836. Simultaneous Webcast With
Moderator Activated Slide Presentation at
http://www.shareholder.com/calypte/medialist.cfm
PLEASANTON, Calif., July 21 /PRNewswire-FirstCall/ -- Calypte Biomedical
Corporation (OTC Bulletin Board: CYPT), announced today that Dr. Richard
George, Calypte's President and Chief Executive Officer, will host a
conference call on Thursday morning at 11:00 am EDT to discuss the recently
concluded XV International AIDS Conference in Bangkok, Thailand, as well as
provide an in-depth discussion of the recently released data from the Thailand
field trials on the Company's HIV-1/2 rapid urine, oral fluid and blood tests.
Investors in the U.S. and Canada interested in participating in the
conference call may dial 800-915-4836 and reference the Calypte Biomedical
call. International investors may dial 973-317-5319.
A live webcast of the conference call accompanied by a moderator activated
slide presentation will be available at
http://www.shareholder.com/calypte/medialist.cfm . The webcast will be
available until August 5, 2004.
A replay of the call will be available through August 5, 2004 by calling
888-203-1112 in the U.S. and Canada and 719-457-0820 for international
listeners. The replay confirmation code is 693031.
The quarterly investors' call on the results of the second quarter ended
June 30, 2004 will be held as a separate call on August 12, 2004.
ABOUT CALYPTE BIOMEDICAL:
Calypte Biomedical Corporation, headquartered in Pleasanton, California,
is a public healthcare company dedicated to the development and
commercialization of in vitro diagnostic tests, primarily for the detection of
antibodies to Human Immunodeficiency Virus (HIV), and other sexually
transmitted and infectious diseases. Calypte's currently marketed laboratory-
based tests include an enzyme immunoassay (EIA) HIV-1 antibody screening test
and an HIV-1 antibody western blot supplemental test, the only two FDA-
approved HIV-1 antibody tests for use on urine samples, as well as an FDA-
approved serum HIV-1 antibody western blot supplemental test. Calypte is
actively engaged in developing new test products for the rapid detection of
HIV and other infectious diseases. Calypte believes that there is a
significant need for rapid detection of such diseases globally to control
their proliferation, particularly in lesser-developed countries, which lack
the medical infrastructure to support laboratory-based testing. Calypte
believes that testing for HIV and other infectious diseases may make important
contributions to public health.
CONTACT:
Dr. Richard George, President and CEO
Calypte Biomedical Corp.
925.730.7200
rgeorge@calypte.com
Tim Clemensen
Rubinstein Investor Relations
212.843.9337
tclemensen@rubensteinir.com
SOURCE Calypte Biomedical Corporation
-0- 07/21/2004
/CONTACT: Dr. Richard George, President and CEO of Calypte Biomedical
Corp., +1-925-730-7200, rgeorge@calypte.com; or Tim Clemensen, of
Rubinstein Investor Relations, +1-212-843-9337, tclemensen@rubensteinir.com
for Calypte Biomedical Corporation/
/Web site: http://www.calypte.com
http://www.shareholder.com/calypte/medialist.cfm /
(CYPT)
CO: Calypte Biomedical Corporation
ST: California, Thailand
IN: HEA MTC BIO OTC
SU: CCA TDS
*** end of story ***
Bio hoffentlich hast du deine Anteile noch!!!!.
JAJAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAendlich
momentan ist das chaos perfekt. ich bleibe natürlich drinn.
wie schon tausend mal gesagt: mein investment wurde beim drücken auf die buy taste auf null abgeschrieben, dh buchhalterisch ist das geld weg unter alles was reinkommt ist ein a.o. Erfolg & der ist liquiditätswirksam *gg*
Langsam kotzt mich der share price an, geb´s ja zu - bin aber weiterhin guter Dinge. Hoffentlich gibts morgen afterhours Fakten. Momentan bringts nicht wirklich viel Spass.
Gruß an alle Longs
;-)
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
"on Thursday morning at 11:00 am EDT"
EDT+6 Stunden = MEZ
Greetz
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
sowas hier.Wat für ein Sch... Niveau, seit manche hier aufgetaucht sind.Und dann echt solche Aussagen wie: "was sehe ich,Caly steht immer noch bei 0,40 Cent wie vor 6,12 und 18 Monaten." ???Oje,oje.Da wird aber ne Brille fällig.Werd mich mal ein wenig zurückhalten, bis man hier wieder Spaß am lesen und schreiben hat.Echt ätzendendes Niveau.Und dabei sollten doch alle erwachsen sein.Eins noch, wenn ich wüßte, das ein Auftrag kommen wird und ich Kohle brauch, würde ich erst recht Aktien ausschütten, solange es geht.Wenn der Auftrag kommt, steigt der Wert meiner Firma rapide und so kann ich auch mal locker ne Übernahme verhindern.Und nun gebts mir doch!Seid doch eh genauso gierige Säcke wie ich. Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
sicht.Hi Lucky. ;O)http://info.consors.de/financeinfos/...attern=&action.x=40&action.y=3
http://info.consors.de/financeinfos/...ttern=&action.x=29&action.y=12
Irgenwo habe ich was gelesen von Aktien in der Luft zerreißen.Na dann mal los.